Mexico is looking to have its own vacancy against the covid-19 before it ends this year. Andrés Manuel López Obrador’s Governor informed this March that the trials and tribulations of the Mexican injection against the coronavirus, carried out as Patria, will take place in April. The vaccine is expected to be unveiled in March 2020 and is based on a recombinant Newcastle disease paramixovirus (rNDV), an infection that affects the eyes. The Mexican Executive, which is working in collaboration with the private pharmaceutical company Avimex, has informed the scheme of the development phase of the immunization for the next months. The chronogram previewed the authorization for its use during the last quarter of 2021.
Avimex Pharmaceuticals is a Mexican company specializing in the development and commercialization of veterinary pharmaceuticals. For this reason, it has contributed to the Mexican vial investigation using the rNDV, which is used in multiple animal products. The company “determined that a recurrent virus of Newcastle’s disease has potential for vaccination against covid-19, through the use of this platform in millions of doses of influenza veterinary vaccines” that it has for sale , announced the company in a communication this March. The affirmative document states that the security of the use of this virus in humans is “extensively tested”.
The President of Mexico has celebrated Patria’s advance with a strong nationalist force. “A vacancy with this number means that we will always think that we will meet the Independents, we will not be found in a globalized world, but we will be self-sufficient in the fundamental, in the basic”, said this March during its morning conference . In addition, the injection was developed with the proven technology of the Icahn School of Medicine of Monte Sinaí, in New York, in the HexaPro protein of the University of Texas, in Austin.
“Imagine what we mean by this vacancy”, he insisted. “It’s not a big deal, because now those who produce vacancies are allowed to sell their territories, there are countries that they are not allowed to live in, and this vacation is for Mexico and other countries.” López Obrador made sure that the vial produced in the country costs less than the buyers have at the moment and will be a “quality” product. No Latin American countries currently have their own proposal. Solo Cuba has launched Phase 3 with its vaccine projects and hopes to have a list below one for the vernacular.
The project to dismantle the munitions directive conducted by the National Council of Science and Technology (Conacyt) and accounts for a budget of 150 million euros for public funds. Phase 1 of the trials, which evaluate vial security and its biological effects, will begin in April and finalize in May. A centenarian of up to 55 years will participate who will be called to form part of a working convocator, said María Elena Álvarez-Buylla, director of Conacyt. Phase 2, which focuses on efficacy, is scheduled for June and July. Phase 3, the last necessary antecedent solicitation of the approval of the regulator, analyzes in depth the results of its application and is scheduled to be realized between August and October. If so, if the results are positive, the Governor will apply for his authorization.
Bernardo Lozano Dubernard, CEO of Avimex, ‘recognized’ the great responsibility he had received ‘in his team with this project. “The cities that are growing and will be indispensable will continue with the support of our collaborators and allies to increase the counter to a safe and effective vaccine that will allow us to contribute to the country’s prosperity in the sector”, he said. through the communication.
Subscribe here a la newsletter of THE PEACE MEXICO AND RECEIVE ALL THE INFORMATION KEYS OF THE UPDATE OF THIS PAIS